Guidance for 2026 now includes a projected 45% to 50% CIS revenue growth, higher than previously discussed. The AI Inference Cloud has moved from launch phase to rapidly scaling, with a large $200 ...
Looking ahead, Akamai guided for fiscal 2026 non-GAAP EPS of $6.20 to $7.20, below the $7.34 consensus estimate. The company expects full-year revenue of $4.4 billion to $4.55 billion and a non-GAAP ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced a partnership with Accord ...
Investing.com -- ImmunityBio (NASDAQ:IBRX) stock surged 17.1% Wednesday after the European Commission granted conditional marketing authorization for the company’s bladder cancer immunotherapy, ...
The memory shortage and price surge have disrupted smartphone shipments, VisEra Technologies — a TSMC-affiliated optical ...
Called HoloRadar, the system enables robots, autonomous vehicles to reconstruct three-dimensional scenes outside their direct line of sight.